Study for the Assessment of the Quality of Echocardiographic Clips.
NCT ID: NCT05090748
Last Updated: 2022-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
240 participants
OBSERVATIONAL
2022-05-15
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study for the Assessment of USEG Software.
NCT05067803
Optimization of an Automated Ultrasound Cardiac Guidance Tool
NCT04981444
ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access
NCT07155434
Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging
NCT03642730
Use of Artificial Intelligence Cardiac Ultrasound Technology in Teaching Point of Care Cardiac Ultrasound
NCT05297877
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the study, eligible subject will undergo the echocardiography examination twice on a single study visit (same day): once by one of the novice users when using the UltraSight AI Guidance software, and once by an expert sonographer without the aid of the software.
Each novice user will perform the examination on at least 20 subjects (with the aim that the number of examinations by each novice will be similar). All examinations will be sent to multiple Board certified cardiologists for their quality evaluations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiographic.
Echocardiographic test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects willing and able to give written informed consent.
Exclusion Criteria
2. Female subjects who are pregnant (women of childbearing potential will perform a urine pregnancy test)
3. Unable to lie as required in all the classic positions for standard TTE exam: supine on back / left decubitus
4. Subjects who currently participate a clinical trial, involving interventional cardiac devices.
5. Subjects who have prior Echo exam with description of Low/Poor quality exam in the echo report
6. Subjects with BMI above 40
7. Subjects experiencing a known or suspected acute cardiac event
8. Subjects with severe chest wall deformity as per previous medical records and physical examination
9. Subjects who have undergone pneumonectomy
10. Subjects whose anatomy does not lend itself to yield diagnosable standard echocardiography clips (i.e. situs inversus with dextrocardia, single ventricle anatomy due to congenital heart disease, etc.).
* A woman is of childbearing potential if she is postmenarchal, has not reached a postmenopausal state (≥12 continuous months of amenorrhea with no identified cause other than menopause), and is not permanently infertile due to surgery (i.e., removal of ovaries, fallopian tubes, and/or uterus) or another cause as determined by the investigator (e.g., Müllerian agenesis.).
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UltraSight
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Lang, MD
Role: PRINCIPAL_INVESTIGATOR
U of Chicago
Federico Asch, MD
Role: PRINCIPAL_INVESTIGATOR
Medstar Health Research Institute
Praveen Mehrotra, MD
Role: PRINCIPAL_INVESTIGATOR
Thomas Jefferson University
Bijoy Khandheria, MD
Role: PRINCIPAL_INVESTIGATOR
Aurora Saint Luke Medical Center
Robert Klampfner, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Danny Spigelstein, MD
Role: STUDY_DIRECTOR
UltraSight
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago Medicine
Chicago, Illinois, United States
Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, United States
Sheba MC
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USEG- 201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.